First, we examined TSP4 protein and mRNA expressions across BLCA cell lines representing different clinical stages—RT4 (stage I), 5637 (stage II), and T24 (stage III)—using Western blot and RT-qPCR analyses. This evidence concerns the gene THBS4 and bladder transitional cell carcinoma.